Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -53.881% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1ccc(NC(=O)CN(C)C(=O)CSc2nnc(C(F)(F)F)n2C)cc1
b. CCc1nccn1CCC(=O)N1CCc2c([nH]c3ccccc23)C1CC(C)C
c. O=C(Cc1ccc2c(c1)OCCO2)N1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1
Answer: b. CCc1nccn1CCC(=O)N1CCc2c([nH]c3ccccc23)C1CC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nccn1CCC(=O)N1CCc2c([nH]c3ccccc23)C1CC(C)C
CCc1nccn1CCC(=O)N1CCc2c([nH]c3ccccc23)C1CC(C)C
3-(2-ethylimidazol-1-yl)-1-[1-(2-methylpropyl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one